Providing a clear and unwavering roadmap of anticipated milestones will ensure that no matter the inevitable bumps or detours, your stakeholders can always see the path forward and track your progress.
Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Data can help healthcare facilities improve patient safety, but first, healthcare leaders need to bring data from multiple sources together using a common taxonomy.
Health data company CuriMeta launched on Tuesday and announced the close of a $6 million seed funding round led by its two institutional partners, BJC HealthCare and the Washington University School of Medicine. The company's mission is to leverage its two institutional partners’ deep data resources to create more useful data that enables quicker discoveries of new diagnostics and medical interventions.
Digital health company Verana Health has raised $150 million. The company said it will use the new capital to expand its technology, which is used by physicians and pharmaceutical companies.
Co-led by Kaiser Permanente, the Series D financing round will enable OM1 to expand its data networks into chronic disease areas, including rheumatology and behavioral health, and advance its AI analytics models.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.